Lifedrink Company (2585) Q3 2025 earnings summary

Executive summary

• Nine-month production quantity rose 13% to 56M cases; revenue increased 17.6% and operating profit rose 4.5%, with sales growth offsetting higher costs.

• Gotemba reached full monthly production in H1 and maintained stable output, but sales volume remained below the initial target amid delays in starting customer transactions.

• Profit attributable to owners of parent increased 5.7% to ¥2,886 million; comprehensive income rose 3.4% to ¥3,035 million.

Financial highlights

• Nine-month revenue was ¥34,545 million and operating profit was ¥4,212 million.

• Gross profit rose to ¥15,222 million from ¥12,567 million year-over-year.

• EBITDA increased 15% to ¥5.566B.

• EPS was ¥55.25 (diluted: ¥55.18), reflecting the 1-for-4 stock split.

Outlook and guidance

• FY2025 revenue forecast is ¥44,000 million, with Q3 progress at 79%; operating profit forecast is ¥5,750 million, with progress at 73%.

• FY2025 ordinary profit is projected at ¥5,650 million and profit attributable to owners of parent at ¥3,850 million; net profit forecast progress was 75%.

• Full-year EBITDA is forecast at ¥7,500 million; forecast EPS is ¥73.67 and dividend is ¥11.25 per share on a post-split basis.

• Gotemba 500ml line expansion targets operation in H2 FY2027/3, with 8M cases annual capacity and ~¥6B investment; Nitto Beverage expansion targets H1 FY2027/3, with 3M cases capacity and ~¥1.6B investment.